Anbio Biotechnology (NNNN) Shares Outstanding (Weighted Average) (2023 - 2025)

Anbio Biotechnology has reported Shares Outstanding (Weighted Average) over the past 3 years, most recently at $43.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $43.7 million for Q4 2025, up 3.27% from a year ago — trailing twelve months through Dec 2025 was $43.7 million (up 3.27% YoY), and the annual figure for FY2025 was $43.7 million, up 3.27%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $43.7 million at Anbio Biotechnology, up from $42.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for NNNN hit a ceiling of $43.7 million in Q4 2025 and a floor of $21.4 million in Q4 2023.
  • Median Shares Outstanding (Weighted Average) over the past 3 years was $42.3 million (2024), compared with a mean of $35.8 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 97.3% in 2024 and later increased 3.27% in 2025.
  • Anbio Biotechnology's Shares Outstanding (Weighted Average) stood at $21.4 million in 2023, then surged by 97.3% to $42.3 million in 2024, then increased by 3.27% to $43.7 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $43.7 million (Q4 2025), $42.3 million (Q4 2024), and $21.4 million (Q4 2023) per Business Quant data.